Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Ashley L. Kiemen

Matched on ORCID iD 0000-0002-6281-2616; OpenAlex author ID A5023048313, A5126300625. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
1
Labs led
0
Collaborators
64
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers, 1 grant · 2024: 2 papers · 2025: 1 paper · 2026: 4 papers

Papers 10

  1. Pancreatic ductal adenocarcinoma: The Vision of Heracles. Co-author DOI 10.1016/j.ccell.2026.07.014↗
  2. Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progression. Co-author DOI 10.1016/j.cpblue.2026.100008↗
  3. Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/science.aec7929↗
  4. Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer Co-author DOI 10.64898/2026.03.03.709150↗
  5. Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model Co-author DOI 10.1101/2025.07.14.664767↗
  6. Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic resp… Co-author DOI 10.1101/2024.09.22.613714↗
  7. Power-law growth models explain incidences and sizes of pancreatic cancer precursor lesions and confirm spatial genomic findings. Co-author DOI 10.1126/sciadv.ado5103↗
  8. Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer. Co-author DOI 10.1016/j.medj.2022.11.009↗
  9. Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer. Co-author DOI 10.1111/his.14839↗
  10. CODA: quantitative 3D reconstruction of large tissues at cellular resolution Co-author DOI 10.1038/s41592-022-01650-9↗

Grants 1

  1. 3D Morphological Analysis of Human Pancreatic Cancer Liver Metastases AWARD lustgarten:2023-ashley-kiemen-phd-3d-morphological-analysis-of-human-pancr

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Laura DeLong Wood · 8 shared papers, 2022–2026 · strength 1.50
  2. Denis Wirtz · 6 shared papers, 2022–2026 · strength 1.14
  3. Ralph H. Hruban · 5 shared papers, 2022–2026 · strength 0.91
  4. Won Jin Ho · 3 shared papers, 2024–2026 · strength 0.60
  5. Toby C. Cornish · 3 shared papers, 2022–2026 · strength 0.58
  6. Pei-Hsun Wu · 3 shared papers, 2022–2026 · strength 0.57
  7. Pei-Hsun wu · 3 shared papers, 2023–2026 · strength 0.56
  8. André Forjaz · 2 shared papers, 2026 · strength 0.46
  9. Dimitrios N. Sidiropoulos · 2 shared papers, 2024–2026 · strength 0.37
  10. Elana Judith Fertig · 2 shared papers, 2024–2026 · strength 0.37
  11. Luciane Tsukamoto Kagohara · 2 shared papers, 2024–2026 · strength 0.37
  12. A. Cole Edwards · 1 shared paper, 2026 · strength 0.23
  13. Minh T. Than · 1 shared paper, 2026 · strength 0.23
  14. Ben Z. Stanger · 1 shared paper, 2026 · strength 0.23
  15. Robert H. Vonderheide · 1 shared paper, 2026 · strength 0.23
  16. David Zwicker · 1 shared paper, 2024 · strength 0.23
  17. Paola A. Guerrero · 1 shared paper, 2026 · strength 0.22
  18. Vincent Bernard Pagan · 1 shared paper, 2026 · strength 0.22
  19. Pilhan Kim · 1 shared paper, 2026 · strength 0.19
  20. Marina Lesina · 1 shared paper, 2026 · strength 0.19
  21. Chiara Falcomatà · 1 shared paper, 2026 · strength 0.19
  22. Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.19
  23. Kıvanç Görgülü · 1 shared paper, 2026 · strength 0.19
  24. Didem Karakaş · 1 shared paper, 2026 · strength 0.19
  25. Yetiş Gültekin · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.